ArticleRenal failure2026
Evaluation of clinicopathological features of renal biopsies in non-lupus rheumatic diseases: a university hospital experience.
Article in Renal failure, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Renal involvement is a common condition in rheumatologic diseases. The aim of this study was to evaluate the clinical presentations and histopathological results in patients diagnosed with non-lupus rheumatic diseases who underwent renal biopsy. The records of 900 renal biopsies performed at our hospital between 2004 and 2023 were retrospectively reviewed, and 139 patients diagnosed with non-lupus rheumatic diseases were included. Data on demographic and clinical characteristics, laboratory results, renal biopsy indications, and histopathological findings were obtained from hospital records. Among the patients, 46 had rheumatoid arthritis (RA), 31 had ankylosing spondylitis (AS), 31 had familial Mediterranean fever (FMF), 17 had Behçet's disease (BD), and 14 had psoriasis (PsO). The most common indication for biopsy was hematuria + subnephrotic proteinuria, accounting for 17.3%. The most frequent pathological diagnosis was amyloidosis (36.7%), followed by focal segmental glomerulosclerosis (FSGS) (19.4%), chronic tubulointerstitial nephritis (TIN) (8.6%), immunoglobulin A (IgA) nephropathy (7.9%), and membranous glomerulonephritis (7.2%). A significant difference was noted among rheumatologic diseases groups according to the reasons for biopsy (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.